Advertisement
Screener

NIAGEN BIOSCIENCE, INC. (NAGE) Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate

2.5 / 5 stars · 44/89 Roast Me

NIAGEN BIOSCIENCE, INC. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate

NIAGEN BIOSCIENCE, INC. (NAGE) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate of 0.00% for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.

Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate · last filed 2026-08-04

  • NIAGEN BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for the quarter ending 2026-03-31 was 0.00%.
  • NIAGEN BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for the quarter ending 2025-03-31 was 0.00%.
  • NIAGEN BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for the quarter ending 2024-03-31 was 0.00%.
  • NIAGEN BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for the quarter ending 2023-03-31 was 0.00%.
  • NIAGEN BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for fiscal 2024 was 0.00%.
  • NIAGEN BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for fiscal 2023 was 0.00%.
  • NIAGEN BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for fiscal 2022 was 0.00%.
  • NIAGEN BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for fiscal 2021 was 0.00%.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 0 monthShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 3 monthShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 6 monthShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 9 monthShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 12 month
2026-06-300.00%
10-Q · filed 2026-08-04
2026-03-310.00%
10-Q · filed 2026-05-06
2025-09-300.00%
10-Q · filed 2025-11-04
2025-06-300.00%
10-Q · filed 2025-08-06
2025-03-310.00%
10-Q · filed 2025-05-07
2024-12-310.00%
10-K · filed 2025-03-04
2024-09-300.00%
10-Q · filed 2024-10-31
2024-06-300.00%
10-Q · filed 2024-08-07
2024-03-310.00%
10-Q · filed 2024-05-08
2023-12-310.00%
10-K · filed 2025-03-04
2023-09-300.00%
10-Q · filed 2023-11-08
2023-06-300.00%
10-Q · filed 2023-08-09
2023-03-310.00%
10-Q · filed 2023-05-10
2022-12-310.00%
10-K · filed 2024-03-06
2022-09-300.00%
10-Q · filed 2022-11-02
2022-06-300.00%
10-Q · filed 2022-08-10
2022-03-310.00%
10-Q · filed 2022-05-12
2021-12-310.00%
10-K · filed 2023-03-08
2021-09-300.00%
10-Q · filed 2021-11-03
2021-06-300.00%
10-Q · filed 2021-08-03
2021-03-310.00%
10-Q · filed 2021-05-06
2020-12-310.00%
10-K · filed 2022-03-14
2020-09-300.00%
10-Q · filed 2020-11-04
2020-06-300.00%
10-Q · filed 2020-08-06
2020-03-310.00%
10-Q · filed 2020-05-18
2019-12-310.00%
10-K · filed 2021-03-12
2019-09-302.00%
10-Q · filed 2019-11-12
2019-06-300.00%
10-Q · filed 2019-08-07
2019-03-310.00%
10-Q · filed 2019-05-09
2018-12-310.00%
10-K · filed 2020-03-10
2018-09-300.00%
10-Q · filed 2018-11-07
2018-06-300.00%
10-Q · filed 2018-08-09
2018-03-310.00%
10-Q · filed 2018-05-10
2017-09-300.00%
10-Q · filed 2017-11-09
2017-07-010.00%
10-Q · filed 2017-08-10
2017-04-010.00%
10-Q · filed 2017-05-11
2016-10-010.00%
10-Q · filed 2016-11-10
2016-07-020.00%
10-Q · filed 2016-08-11
2016-03-110.00%
10-Q · filed 2016-11-10
2015-10-030.00%
10-Q · filed 2015-11-12
2015-07-040.00%
10-Q · filed 2015-08-13
2015-04-040.00%
10-Q · filed 2015-05-14
2014-09-270.00%
10-Q · filed 2014-11-06
2014-06-280.00%
10-Q · filed 2014-08-12
2014-03-290.00%
10-Q · filed 2014-05-08
2012-12-290.00%
10-K · filed 2013-03-29
2011-12-310.00%
10-K · filed 2013-03-29

Similar stocks

Stock NameCountryMarket CapPE Ratio
USANA HEALTH SCIENCES INC (USNA)United States$0.264B-17.90
FITLIFE BRANDS, INC. (FTLF)United States$0.087B16.59
Canopy Growth Corp (CGC)$0.395B
MANNATECH INC (MTEX)United States$0.014B
NATURAL ALTERNATIVES INTERNATIONAL INC (NAII)United States$0.011B-1.16
Synergy CHC Corp. (SNYR)United States$0.001B
Functional Brands Inc. (MEHA)United States$0.001B
Tilray Brands, Inc. (TLRY)United States$0.554B-5.97
Cronos Group Inc. (CRON)$1.223B
Definium Therapeutics, Inc. (DFTX)United States$4.931B-17.87